Back to search
FDAFDA · Food and drugs·Recall number D-0219-2018

Mefenamic Acid Capsules, USP, 250 mg, 30-count bottle, Rx only, Distributed by Prasco Laboratories, Mason, OH 45040, Manufactured by Halo Pharmaceutical Inc., Whippany, NJ 07981, NDC 66993-070-30

Published January 24, 2018 · Recall initiated: May 24, 2017

Summary

FDA records drug Class III recall D-0219-2018, published January 24, 2018 and initiated May 24, 2017. Recalling firm: Shionogi Inc.; Status: Terminated; Reported quantity: 968 bottles; Lot: Lot#: 7H66200103G, Exp 12/19. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of foreign substance: The recall was initiated due to black particles being observed while performing routine post-release stability testing on Mefenamic acid capsules

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Shionogi Inc.
Distributor
U.S.A. Nationwide
Lot
Lot#: 7H66200103G, Exp 12/19
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Mefenamic Acid Capsules, USP, 250 mg, 30-count bottle, Rx only, Distributed by Prasco Laboratories, Mason, OH 45040, Manufactured by Halo Pharmaceutical Inc., Whippany, NJ 07981, NDC 66993-070-30 recalled?

Yes. FDA published recall D-0219-2018 on January 24, 2018. Reported hazard: Presence of foreign substance: The recall was initiated due to black particles being observed while performing routine post-release stability testing on Mefenamic acid capsules

What should I do if I have this product?

Voluntary: Firm initiated · Letter